|Grant Affiliation:||Weiss: Protection by Neutralizing Antibodies|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Pre-Clinical Non-NHP|
|Study Start Date:||2008-03-27|
|Study Made Public:||2012-04-04|
CAVD 291 is an antibody production study using ZM96 gp140 as an immunogen to raise neutralizing monoclonal antibodies in humanized Ig mice.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.